Barinthus Biotherapeutics Plc Stock Price on September 12, 2024
| BRNS Stock | 0.89 0.10 10.10% |
If you're considering investing in Barinthus Stock, it is important to understand the factors that can impact its price. As of today, the current price of Barinthus Biotherapeutics stands at 0.89, as last reported on the 25th of November, with the highest price reaching 1.02 and the lowest price hitting 0.89 during the day. Barinthus Biotherapeutics secures Sharpe Ratio (or Efficiency) of -0.0604, which signifies that the company had a -0.0604% return per unit of risk over the last 3 months. Barinthus Biotherapeutics plc exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Barinthus Biotherapeutics' Standard Deviation of 5.74, risk adjusted performance of (0.04), and Mean Deviation of 3.53 to double-check the risk estimate we provide.
At this time, Barinthus Biotherapeutics' Common Stock is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 7 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 136.9 M in 2024. . Price Earnings To Growth Ratio is likely to gain to 0 in 2024, whereas Price To Sales Ratio is likely to drop 167.79 in 2024. Barinthus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Barinthus |
Sharpe Ratio = -0.0604
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BRNS |
Estimated Market Risk
| 5.76 actual daily | 51 51% of assets are less volatile |
Expected Return
| -0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Barinthus Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Barinthus Biotherapeutics by adding Barinthus Biotherapeutics to a well-diversified portfolio.
Price Book 0.226 | Enterprise Value Ebitda (6.67) | Price Sales 2.4045 | Shares Float 28.2 M | Wall Street Target Price 7.1667 |
Related Headline
Bridgford Foods Headline on 12th of September 2024
Acquisition by Bridgford Allan Jr. of tradable shares of Bri... by Bridgford Allan Jr.
Filed transaction by Bridgford Foods Other Consultant. Grant, award or other acquisition pursuant to Rule 16b-3
Barinthus Biotherapeutics Valuation on September 12, 2024
It is possible to determine the worth of Barinthus Biotherapeutics on a given historical date. On September 12, 2024 Barinthus was worth 1.25 at the beginning of the trading date compared to the closed value of 1.28. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Barinthus Biotherapeutics stock. Still, in general, we apply an absolute valuation method to find Barinthus Biotherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Barinthus Biotherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Barinthus Biotherapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.25 | 1.29 | 1.23 | 1.23 | 13,291 | |
09/12/2024 | 1.25 | 1.31 | 1.23 | 1.28 | 51,112 |
| 1.28 | 1.31 | 1.26 | 1.27 | 15,463 |
| Backtest Barinthus Biotherapeutics | | | Barinthus Biotherapeutics History | | | Barinthus Biotherapeutics Valuation | Previous | Next |
Barinthus Biotherapeutics Trading Date Momentum on September 12, 2024
| On September 13 2024 Barinthus Biotherapeutics plc was traded for 1.27 at the closing time. The top price for the day was 1.31 and the lowest listed price was 1.26 . The trading volume for the day was 15.5 K. The trading history from September 13, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.78% . The overall trading delta against the current closing price is 0.78% . |
Barinthus Biotherapeutics Fundamentals Correlations and Trends
By evaluating Barinthus Biotherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Barinthus Biotherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Barinthus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Barinthus Biotherapeutics Stock history
Barinthus Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Barinthus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Barinthus Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Barinthus Biotherapeutics stock prices may prove useful in developing a viable investing in Barinthus Biotherapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 38.4 M | 32.5 M | |
| Net Loss | -45.8 M | -48.1 M |
Barinthus Biotherapeutics Quarterly Net Working Capital |
|
Barinthus Biotherapeutics Stock Technical Analysis
Barinthus Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Barinthus Biotherapeutics Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Barinthus Biotherapeutics plc cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Barinthus Biotherapeutics November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Barinthus Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Barinthus Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Barinthus Biotherapeutics stock market strength indicators, traders can identify Barinthus Biotherapeutics plc entry and exit signals to maximize returns
Barinthus Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Barinthus Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Barinthus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Barinthus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.45) | |||
| Total Risk Alpha | (1.25) | |||
| Treynor Ratio | (0.40) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Barinthus Stock Analysis
When running Barinthus Biotherapeutics' price analysis, check to measure Barinthus Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Barinthus Biotherapeutics is operating at the current time. Most of Barinthus Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Barinthus Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Barinthus Biotherapeutics' price. Additionally, you may evaluate how the addition of Barinthus Biotherapeutics to your portfolios can decrease your overall portfolio volatility.